Statements (66)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Company
|
gptkbp:bfsLayer |
4
|
gptkbp:bfsParent |
gptkb:IQVIA
|
gptkbp:acquisition |
Acquired by Quintiles in 2016
|
gptkbp:ceo |
gptkb:Sharon_D._Dyer
|
gptkbp:employees |
Over 1,000
|
gptkbp:focus_area |
gptkb:Database_Management_System
gptkb:healthcare_organization gptkb:hospital gptkb:Company gptkb:sneaker gptkb:software gptkb:Insurance_Company gptkb:project Biostatistics Gastroenterology Immunology Transplantation Urology Neurology Infectious Diseases Patient Recruitment Regulatory Compliance Vaccine Development Endocrinology Hematology Patient Engagement Risk-Based Monitoring Dermatology Regulatory Affairs Diagnostics Training and Education Respiratory Diseases Rare Diseases Biopharmaceuticals Cardiovascular Site Management Regulatory Submissions Metabolic Disorders Pharmacovigilance Clinical Development Cell and Gene Therapy Laboratory Information Management Systems Women’s Health Clinical Trial Optimization Clinical Pharmacology Patient-Centric Solutions Analytical Testing Real World Evidence Biomarker Development Bioanalytical Services Clinical Supply Management Health Economics and Outcomes Research Artificial Intelligence in Clinical Trials Clinical Data Integration Immunogenicity Testing Therapeutic Expertise |
gptkbp:founded |
gptkb:2003
|
gptkbp:global_presence |
Worldwide
|
gptkbp:headquarters |
gptkb:Durham,_North_Carolina
|
https://www.w3.org/2000/01/rdf-schema#label |
Q2 Solutions
|
gptkbp:industry |
Clinical Research
|
gptkbp:parent_company |
Quintiles IMS
|
gptkbp:services |
gptkb:Research_Institute
Clinical Trial Services |
gptkbp:website |
www.q2solutions.com
|